Crossmark

Response to the Comment by Van den Reek et al. on Drug Survival Analysis is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis

Crossref DOI link: https://doi.org/10.1016/j.adengl.2017.03.040

Published Print: 2017-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dávila-Seijo, P.

García-Doval, I.
License Information

Text and Data Mining valid from 2017-09-01

Version of Record valid from 2020-09-03
More Information

This article is maintained by: Elsevier

Article Title: Response to the Comment by Van den Reek et al. on Drug Survival Analysis is Not a Good Method for Assessing the Safety or Effectiveness of Systemic Therapies in Psoriasis

Journal Title: Actas Dermo-Sifiliográficas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.adengl.2017.03.040

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.ad.2017.03.011

Content Type: simple-article

Copyright: © 2017 Elsevier España, S.L.U. and AEDV.

Document is current

Any future updates will be listed below